Proxygen GmbH | Finanzwire

Basculer en Français

10936	Companies
238805	Keywords
167666	Articles
128365	Press releases

Home
Companies
Proxygen GmbH

BRIEF

published on 04/28/2026 at 14:05, 4 months 6 days ago

Proxygen Advances in Induced Proximity Therapeutics with New Programs

Biotechnology Cancer Therapeutics Proxygen Induced Proximity
PRESS RELEASE

published on 04/28/2026 at 14:00, 4 months 6 days ago

Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
Proxygen announces expansion of platform to develop next-generation induced proximity therapeutics, advancing p300 and CDK12 programs focused on multiple cancer types

Drug Discovery Molecular Glue Degraders Proxygen Induced Proximity Therapeutics Cancer Types
BRIEF

published on 03/31/2026 at 14:05, 5 months 4 days ago

Proxygen Names Chiara Conti as Chief Scientific Officer

Biotechnology Clinical Development Molecular Glue Degraders Proxygen GmbH Chiara Conti
PRESS RELEASE

published on 03/31/2026 at 14:00, 5 months 4 days ago

Proxygen Appoints Chiara Conti, Ph.D. as Chief Scientific Officer to Drive Clinical Translation and Expand Induced Proximity Platform Beyond Degradation
Proxygen appoints Dr. Chiara Conti as Chief Scientific Officer to drive clinical translation and expand induced proximity platform. Company transitions to clinical-stage execution with a focus on advancing the pipeline

Chief Scientific Officer Clinical Translation Chiara Conti Proxygen Proximity-based Therapeutics

Accesswire

Published on 09/04/2026 at 23:30, 1 hour 50 minutes ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 hours 20 minutes ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 hours 50 minutes ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 10 hours 50 minutes ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/04/2026 at 14:00, 11 hours 20 minutes ago

Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair

View all ACCESSWIRE

EQS Group

Published on 09/04/2026 at 22:10, 3 hours 10 minutes ago

Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
Published on 09/04/2026 at 19:20, 6 hours ago

Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026
Published on 09/04/2026 at 18:55, 6 hours 25 minutes ago

Holding(s) in Company
Published on 09/04/2026 at 18:50, 6 hours 30 minutes ago

A&S Resources secures railway funding of USD$6 Billion to unlock $2.5 trillion iron ore asset
Published on 09/04/2026 at 18:05, 7 hours 15 minutes ago

Grundig Unveils New Product Lineup at IFA 2026, Marking a New Phase in Strategic Partnership

Les Echos

Published on 09/04/2026 at 18:57, 6 hours 23 minutes ago

Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 7 hours 35 minutes ago

Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 17:45, 7 hours 35 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 09/04/2026 at 16:00, 9 hours 20 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 9 hours 20 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

View all LES ECHOS COMFI WIRE